These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 2143598)
21. A double-blind study to compare the efficacy, tolerance and safety of two doses of the angiotensin converting enzyme inhibitor ramipril with placebo. Villamil AS; Cairns V; Witte PU; Bertolasi CA Am J Cardiol; 1987 Apr; 59(10):110D-114D. PubMed ID: 3034017 [TBL] [Abstract][Full Text] [Related]
22. Metabolic effects of ramipril treatment in hypertensive subjects with non-insulin-dependent diabetes mellitus. Janka HU; Nuber A; Mehnert H Arzneimittelforschung; 1990 Apr; 40(4):432-5. PubMed ID: 2141472 [TBL] [Abstract][Full Text] [Related]
23. Efficacy, tolerance and hormonal effects of a new oral angiotensin converting enzyme inhibitor, ramipril (HOE 498), in mild to moderate primary hypertension. Karlberg BE; Lindström T; Rosenqvist U; Ohman KP Am J Cardiol; 1987 Apr; 59(10):104D-109D. PubMed ID: 3034016 [TBL] [Abstract][Full Text] [Related]
24. Comparison of ramipril against atenolol in controlling mild-to-moderate hypertension. Lenox-Smith AJ; Street RB; Kendall FD J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S150-2. PubMed ID: 1725029 [TBL] [Abstract][Full Text] [Related]
25. Effects of the new angiotensin-converting enzyme inhibitor, ramipril, in patients with essential hypertension. Stumpe KO; Overlack A; Kolloch R; Schatz J; Witte PU; Pahnke K Klin Wochenschr; 1986 Jun; 64(12):558-62. PubMed ID: 3016405 [TBL] [Abstract][Full Text] [Related]
26. Comparative double-blind study of ramipril and captopril in mild to moderate essential hypertension. Witte PU; Walter U Am J Cardiol; 1987 Apr; 59(10):115D-120D. PubMed ID: 3034018 [TBL] [Abstract][Full Text] [Related]
27. Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats. Moursi MG; Ganten D; Lang RE; Unger T J Hypertens Suppl; 1986 Oct; 4(3):S495-8. PubMed ID: 3023591 [TBL] [Abstract][Full Text] [Related]
28. Combined treatment of severe essential hypertension with the new angiotensin converting enzyme inhibitor ramipril. Predel HG; Düsing R; Bäcker A; Kipnowski J; Kramer HJ Am J Cardiol; 1987 Apr; 59(10):143D-148D. PubMed ID: 3034023 [TBL] [Abstract][Full Text] [Related]
29. Ramipril: a review of the new ACE inhibitor. Mills TP J Ark Med Soc; 1992 Feb; 88(9):437-40. PubMed ID: 1532570 [TBL] [Abstract][Full Text] [Related]
30. Ramipril for hypertension secondary to renal artery stenosis. Changes in blood pressure, the renin-angiotensin system and total and divided renal function. Tillman DM; Adams FG; Gillen G; Morton JJ; Robertson JI Am J Cardiol; 1987 Apr; 59(10):133D-142D. PubMed ID: 3034022 [TBL] [Abstract][Full Text] [Related]
31. Antihypertensive efficacy, tolerance, and safety of long-term treatment with ramipril in patients with mild-to-moderate essential hypertension. Schreiner M; Berendes B; Verho M; Langley A; Cairns V J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S137-40. PubMed ID: 1725024 [TBL] [Abstract][Full Text] [Related]
32. Tolerability of ramipril in a multicenter study of mild-to-moderate hypertension in general practice. Carré A; Vasmant D; Elmalem J; Thiéry P J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S141-3. PubMed ID: 1725026 [TBL] [Abstract][Full Text] [Related]
33. Comparison of response rates to the angiotensin-converting enzyme inhibitor ramipril in mild-to-moderate hypertension in a double-blind, parallel-group study and an open single-blind study. Vasmant D; Lendresse P; Lemarie JC; Gallet M J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S144-6. PubMed ID: 1725027 [TBL] [Abstract][Full Text] [Related]